Abstract

Background: Pulmonary alveolar proteinosis (PAP) is a rare disorder which is categorized into congenital, idiopathic and secondary types. There is a marked paucity of literature from the Indian subcontinent that analyses the causation of PAP. Methods: We studied clinical features, histopathological findings and cytological features in 19 bronchoalveolar lavage (BAL) cytology confirmed cases of PAP diagnosed over a 28-year period. Results: One or more risk factors for PAP were noted in 11 cases (57.89%) and included exposure to silica dust, chemicals, smoke and flour, immunological diseases, tuberculosis, retroviral disease and monoclonal gammopathy. Three patients had more than one risk factor. Only one patient was tested for anti-granulocyte-monocyte colony-stimulating-factor (anti-GM-CSF) antibodies. Elevated anti-GM-CSF antibodies and absence of an identifiable risk factor was noted in this patient. Super-infection was noted in three (15.79%); with tuberculosis in two and aspergillosis in one. Six patients had a recent past history of anti-tuberculosis therapy but only one among them had documented acid fast bacilli positivity confirming tuberculosis and autopsy revealed tuberculosis in one patient. Conclusion: The present study observed that a considerable proportion of cases were associated with known risk factors for PAP. A variable relationship of PAP and tuberculosis was observed where the latter was noted as a possible risk factor, a co-existing disease at presentation, a superinfection, or even a possible cause of a misdiagnosis of PAP as tuberculosis. These findings are of great relevance in view of the endemicity of tuberculosis in India.

Highlights

  • Pulmonary alveolar proteinosis (PAP) is an uncommon disorder characterised by accumulation of lipoproteinaceous material in the alveoli and is classified into congenital, idiopathic and secondary categories[1]

  • Only bronchoalveolar lavage (BAL) cytology and/ or lung histopathology provides a definitive diagnosis[4]. It may have an unusual presentation leading to a misdiagnosis as a more common respiratory disorder that includes even tuberculosis . [5,6] This study presents the data of clinical features and cytological / histological findings of PAP with emphasis on the multifarious association of PAP with tuberculosis

  • We retrospectively reviewed a total of 19 cases from 1991 to 2018 wherein BAL fluid cytology had revealed the characteristic exudate of PAP - granular to clumpy, dark pink, paucicellular, proteinaceous material on routine hematoxylin and eosin (H & E) staining (Figure 1) with diastase resistant periodic acid-Schiff (PAS-DR) positivity (Figure 2)

Read more

Summary

Introduction

Pulmonary alveolar proteinosis (PAP) is an uncommon disorder characterised by accumulation of lipoproteinaceous material in the alveoli and is classified into congenital, idiopathic (auto-immune) and secondary categories[1]. Only bronchoalveolar lavage (BAL) cytology and/ or lung histopathology provides a definitive diagnosis[4]. It may have an unusual presentation leading to a misdiagnosis as a more common respiratory disorder that includes even tuberculosis . [5,6] This study presents the data of clinical features and cytological / histological findings of PAP with emphasis on the multifarious association of PAP with tuberculosis. Pulmonary alveolar proteinosis (PAP) is a rare disorder which is categorized into congenital, idiopathic and secondary types.

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.